Projects per year
ADVANCE-outcomes: A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of care or PAH-specific background therapy in subjects with World Health Organization (WHO) Group 1 PAH: APD811-301
Brown, M., Butala, R. & Chapman, N.
17/10/19 → 30/06/22
Speckle-tracking Global Longitudinal Strain (GLS) for Early Detection of Cardiotoxicity from Anticancer Therapy
Respiratory muscle training to improve exercise capacity and quality of life in people with pulmonary arterial hypertension
Brown, M., Rachael, C., Davis, G., Celermajer, D., Alison, J., Lau, E., Lindstrom, S., Coy, A. & Tran, D.
Brown, M., Grieve, S., Cutty, S., Figtree, G. A., Lau, E., Muthurangu, V., Lovell, N., La Gerche, A., Lim, E. & Celermajer, D.